Full-Time
Health and Safety Coordinator
Posted on 11/7/2025
Inizio Engage
501-1,000 employees
Provides integrated data insights for pharma
No salary listed
Philadelphia, PA, USA
Hybrid
Hybrid role; national and international travel required.
 Legal & Compliance (1) |
|---|
- A Bachelor's degree in any discipline
- A willingness to learn and develop in the role and organization through professional qualifications and training
- Knowledge of OSHA Regulations and procedures
- A valid passport to allow international travel
- Advanced IT skills
- This is a fully remote position; however, we are looking for candidates in the Greater Philadelphia region
- The role includes national travel and international travel
- Assist the Safety Team with the maintenance, review and ongoing improvement of all safety documents and procedures
- Maintain the training records, booking and scheduling relevant courses, and assisting with the creation of training materials
- Engage with your professional development to build competencies, through formal qualifications and on the job training, to progress within the role and organisation
- Help with the creation of regular reports and business updates
- Support the development and update of internal guidance and information for employees and suppliers to better inform each of the Health & Safety expectations of the business
- Coordinate and communicate health and safety activities throughout the business
- Support the Safety Team with administrative tasks concerning ongoing projects, including creating safety plans and risk assessments for project activities
- Support the development and distribution of internal communications
- Creation and communication of audit reports including the maintenance of action plans for any required
- Support with on-site safety tasks alongside the wider Safety Team
- Assist the Office Team with maintaining regulatory health and safety compliance across XD facilities
- Experience working in the live events, exhibitions or entertainment sector
Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Dublin Township, Pennsylvania
Founded
N/A
Simplify's Take
What believers are saying
- Nazaré Access Academy addresses growing US patient access complexity for pharma.
- PROPENSITY4 transforms disparate data into integrated insights for commercial optimization.
- Strategic leadership appointments signal potential for streamlined operations and market expansion.
What critics are saying
- Nazaré brand consolidation cannibalizes legacy divisions' revenue within 6-12 months.
- IQVIA's integrated platforms directly compete with PROPENSITY4's data analytics services.
- AI-powered learning platforms displace human-led training, halving demand by 2028.
What makes Inizio Engage unique
- End-to-end commercialization partner spanning discovery through post-launch lifecycle.
- Integrated suite connecting medical affairs, data insights, and creative engagement capabilities.
- 5,000+ professionals across 20+ countries delivering localized pharmaceutical expertise globally.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Private Medical Insurance
Life Insurance
Pension Scheme
Hybrid Work Options
Paid Vacation
401(k) Retirement Plan
Company News
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50
We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.
Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.
After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.
Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.